Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

A Comparison of the Effects of Exercise Methods for Adolescent Hyperkyphosis on the Sensorimotor System

2. november 2026 oppdatert av: Ayse Zengin Alpozgen, Istanbul University - Cerrahpasa

Comparıson Of The Effects Of Schroth And Conventıonal Exercıses On The Sensorımotor System In Adolescents Wıth Hyperkyphosıs

This study will compare two home exercise programs for adolescents aged 10-17 years with postural hyperkyphosis: kyphosis-specific Schroth exercises and traditional stretching and strengthening exercises. It will examine whether one program is more effective at improving the ability to sense and reproduce a corrected upper-back posture. The researchers expect the Schroth program to lead to greater improvement.

Studieoversikt

Detaljert beskrivelse

This study will compare two home-based exercise programs for adolescents aged 10-17 years with postural hyperkyphosis. Participants will follow either kyphosis-specific Schroth exercises or conventional stretching, strengthening, and stabilization exercises for eight weeks, approximately 45 minutes per session, three days a week.

The study will assess whether the programs affect participants' ability to recognize and reproduce a corrected thoracic posture. Other outcomes will include balance, spinal curvature and posture, muscle strength and endurance, flexibility, spinal pain, and participants' perceptions of their condition and overall change. Exercise participation, how accurately the exercises are performed, and any adverse events will also be recorded.

Studietype

Intervensjonell

Registrering (Antatt)

58

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Bakırköy
      • Istanbul, Bakırköy, Tyrkia (Türkiye)
        • Istanbul University-Cerrahpaşa, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ayşe Zengin Alpözgen, Assoc. Prof.
        • Underetterforsker:
          • Kübra Kardeş, Asst Prof.
        • Underetterforsker:
          • Çisemnur Gülnaz, BSc

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

10 år til 17 år (Barn)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Aged 10 through 17 years. Thoracic kyphosis Cobb angle greater than 40° and less than 70° from T4 to T12 on a lateral radiograph.

Flexible thoracic kyphosis that decreases with active correction on clinical examination.

Able to understand the exercise instructions and perform the home program. Written informed consent from a parent or legal guardian and written assent from the adolescent.

Exclusion Criteria:

Kyphosis other than postural kyphosis, including Scheuermann disease (at least 5° of wedging in three or more consecutive vertebrae), congenital kyphosis, or other structural or rigid kyphosis.

Structural scoliosis with a Cobb angle greater than 10°. Previous spinal surgery or major trauma affecting the spine. A diagnosed neurological condition or neurological symptoms that may affect postural control.

Diagnosed vestibular pathology or a history of vestibular problems, or current vertigo, dizziness, or balance complaints.

Visual impairment that cannot be corrected with glasses or contact lenses. Acute musculoskeletal injury or pain that would prevent assessment or exercise. Participation in physiotherapy or an exercise program for kyphosis within the previous 3 months.

Previous Schroth exercise training. Current brace treatment. Cognitive impairment that would prevent adherence to the exercise program.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Schroth exercise group

This group will perform a kyphosis-specific Schroth exercise program focused on active thoracic posture correction, axial elongation, and corrective breathing. Participants will practice the exercises at home, using a mirror for visual feedback and tactile cues to monitor their posture.

Participants will perform the program at home 3 days per week for 8 weeks, with each session lasting approximately 45 minutes, including a 5-minute warm-up and a 3-minute cool-down. Three face-to-face training sessions will be provided during week 1, followed by face-to-face follow-up visits at the beginning of weeks 3 and 5. The program will have two stages. Participants who meet the prespecified progression criteria will advance to stage 2 at the week 5 follow-up.

Aktiv komparator: Conventional exercise group

This group will perform a conventional exercise program including stretching, scapular retraction, back extensor and trapezius strengthening, and trunk stabilization. The program will not include Schroth-specific active posture correction, corrective breathing, or mirror-based posture feedback.

Participants will perform the program at home 3 days per week for 8 weeks, with each session lasting approximately 45 minutes, including a 5-minute warm-up and a 3-minute cool-down. Three face-to-face training sessions will be provided during week 1, followed by face-to-face follow-up visits at the beginning of weeks 3 and 5. The program will have two stages. Participants who meet the prespecified progression criteria will advance to stage 2 at the week 5 follow-up.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Thoracic Extension Absolute Repositioning Error
Tidsramme: At baseline and at the end of Week 8

Thoracic position sense will be assessed with dual digital inclinometers placed at T1 and T12. With eyes closed, participants will reproduce a 15° thoracic extension target. The primary measure is the mean absolute difference between the target and reproduced angles across five trials, in degrees; lower values indicate smaller error. Flexion (30°) and right and left lateral flexion (20°) will also be measured as secondary directional outcomes.

At baseline and at the end of Week 8

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Balance
Tidsramme: At baseline and at the end of Week 8

Balance will be assessed with the AI Balance system using the modified Clinical Test of Sensory Interaction on Balance (four eyes-open/eyes-closed conditions on firm and foam surfaces; three 30-second trials per condition) and the Limits of Stability test (weight shifting toward eight targets). Higher sway index values indicate greater sway; higher Limits of Stability scores indicate better performance.

At baseline and at the end of Week 8
Thoracic Curvature
Tidsramme: At baseline and at the end of Week 8

Thoracic curvature will be measured with a Flexicurve ruler from C7 to T12. The kyphosis index will be calculated as the kyphosis apex depth divided by the curve length, multiplied by 100. The values above 13 indicate hyperkyphosis.

At baseline and at the end of Week 8
Sagittal Posture
Tidsramme: At baseline and at the end of Week 8

Sagittal posture will be assessed from a lateral photograph using the PostureScreen Mobile application. Landmark displacement will be recorded in centimeters under standardized camera, posture, clothing, and hair conditions.

At baseline and at the end of Week 8
Muscle Strength
Tidsramme: At baseline and at the end of Week 8

Isometric strength of the trunk flexors and extensors, upper, middle, and lower trapezius, and serratus anterior will be measured using a hand-held dynamometer and the make-test method. Three 5-second contractions will be performed for each muscle group. Mean force will be normalized to body weight and reported in N/kg.

At baseline and at the end of Week 8
Flexibility
Tidsramme: At baseline and at the end of Week 8

Hamstring and lower-back flexibility will be measured with the sit-and-reach test; the maximum distance across three trials will be recorded in centimeters. Pectoralis minor muscle length will be measured bilaterally with a tape measure; the mean of three measurements will be analyzed.

At baseline and at the end of Week 8
Muscle Endurance
Tidsramme: At baseline and at the end of Week 8

Scapular, trunk flexor, and trunk extensor endurance will be assessed using the isometric scapular endurance, McGill trunk flexor endurance, and Biering-Sørensen tests, respectively. The time each position is maintained without compensation will be recorded in seconds. Each test will be performed once, with at least 5 minutes of rest between tests.

At baseline and at the end of Week 8
Spinal Pain
Tidsramme: At baseline and at the end of Week 8

Resting, activity-related, and nocturnal spinal pain during the previous week will be rated on a 0-10 cm Visual Analog Scale, where 0 indicates no pain and 10 indicates the worst possible pain.

At baseline and at the end of Week 8
Deformity Perception
Tidsramme: At baseline and at the end of Week 8

Deformity perception will be assessed with the Turkish version of the Kyphosis-Specific Spinal Appearance Questionnaire. The 10-item questionnaire is scored from 1 to 5; the mean item score will be analyzed. Higher scores indicate a more negative perception of spinal appearance.

At baseline and at the end of Week 8
Perceived Global Change
Tidsramme: At the end of Week 8

Overall perceived change will be assessed using the 7-point Global Rating of Change scale, from -3 (much worse) to +3 (much better), with 0 indicating no change. Scores of +2 or +3 will indicate a clinically meaningful perceived improvement.

At the end of Week 8

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

15. november 2026

Primær fullføring (Antatt)

15. mai 2027

Studiet fullført (Antatt)

15. juni 2027

Datoer for studieregistrering

Først innsendt

2. november 2026

Først innsendt som oppfylte QC-kriteriene

2. november 2026

Først lagt ut (Faktiske)

6. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

2. november 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere